Strategic Research Sponsor of the American Bar Association's Section of International Law

Eric Grannon

Eric Grannon
701 Thirteenth Street, NW
District of Columbia
+ 1 202 626 3600


Who's Who Legal Competition: Future Leaders - Partners

Mr Grannon helps clients with civil and criminal antitrust defence, counselling for mergers and acquisitions, and settlements of pharmaceutical patent litigation. Since 2001, he has also helped clients with concerns under the Foreign Corrupt Practices Act (FCPA). He began at the firm as a summer associate in 1997 and has been a partner since 2007.

A former prosecutor, Mr Grannon returned to the firm after serving as counsel to the assistant attorney general in charge of the antitrust division at the DOJ (2003-2004), where he helped formulate US enforcement policy and manage the Division’s civil and criminal matters.

In private practice, Mr Grannon has argued in district courts across the country, including an antitrust jury trial, argued appeals in the Eleventh and DC Circuits, and worked on 11 matters before the US Supreme Court, 10 of which were antitrust cases. His experience in pharmaceutical antitrust includes: acting as counsel of record in FTC v Actavis, 133 S. Ct. 2223 (2013), which rejected the FTC’s presumption of illegality in favor of the rule of reason (currently serving as lead trial counsel for two pharmaceutical companies in the remand litigation); successfully arguing motion for summary judgment against the sham-litigation claims of class plaintiffs in AndroGel Antitrust Litigation, 888 F. Supp. 2d 1336 (N.D. Ga. 2012); and acting as lead counsel for over 30 pharmaceutical patent settlements that have avoided challenge by the FTC and class-action bar

Other class-action defence includes acting as co-lead counsel for petitioners in the defence win in Stolt-Nielsen v AnimalFeeds Int’l, 130 S. Ct. 1758 (2010), which changed US law by making it harder for plaintiffs to assert class-action claims in arbitration.

In criminal antitrust he acted as lead counsel for a Taiwanese semiconductor manufacturer in both the DOJ’s SRAM investigation (which concluded in no indictment despite the cooperation of the amnesty applicant) and the parallel class-actions; as co-lead counsel defending a non-US executive in DOJ’s DRAM investigation; as lead author of successful motion for a bill of particulars, forcing DOJ to supplement its barebones, formulaic indictment with detailed allegations (United States v Kim, No. 06-0692 (N.D. Cal. Mar. 1, 2007)); and as counsel in United States v Stolt-Nielsen, 524 F. Supp. 2d 609 (E.D. Pa. 2007) (successfully enforcing amnesty agreement against DOJ’s attempted revocation).

In mergers and acquisitions work, he has acted as lead counsel advising a leading US tobacco company on the formation of a joint venture for the development of intellectual property; for an innovator pharmaceutical company in a cross-border acquisition and product development agreement; and in obtaining early termination of the HSR waiting period for review of Iron Mountain's acquisition of Archives One.

Mr Grannon clerked for the Honorable Walter K Stapleton, US Court of Appeals for the Third Circuit, 1999-2000, and the Honorable Federico A Moreno, US District Court for the Southern District of Florida, 1998-1999.

He is serving a three-year term on the ABA’s standing committee on amicus curiae briefs. He previously served as vice chair of the healthcare and pharmaceuticals committee of the ABA section of antitrust law, and prior to that as vice chair of its compliance and ethics committee.

He was an adjunct at the Howard University School of Law, his alma mater, where he taught a seminar on advanced antitrust law.

WWL says: Eric Grannon is "one of the rising stars of the antitrust bar" who is particularly noted for his "excellent experience in the pharmaceuticals sector".

This biography is an extract from Who's Who Legal: Competition which can be purchased from our Shop.

Follow us on LinkedIn

Practice Areas


Browse Firms

Search Firms

The Who's Who Legal 100


News & Features

Special Reports



About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2018 Law Business Research Ltd. All rights reserved. |

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910 |

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK